FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to pharmaceutics. First invention is a pharmaceutical composition for treating a condition of severe pain, comprising: a) from 20 to 30 wt% Ibuprofen or Naproxen; b) a pharmaceutically acceptable glycerol lipid comprising a mixture of saturated C10-C18 triglycerides having a melting point between 41 °C and 45 °C in an amount of 30 to 50 wt%, and glyceryl monolinoleate in an amount of 20 to 40 wt%; c) a pharmaceutically acceptable liquid polyethylene glycol in an amount of less than 15 wt%; the composition does not contain surfactants; the composition is designed to be a solid at 15 °C or lower and has a melting point of 30 °C or above. Second invention is the use of this composition in the manufacture of a medicament for the treatment of a condition of severe pain. Third invention is the use of this composition to treat a condition of severe pain. Fourth invention is a method of treating an individual with a condition of severe pain, comprising a step of administering said composition.
EFFECT: group of inventions provides a composition in the form of a solid solution, which leads to an increase in its storage stability, as well as selective and directed distribution in macrophages upon administration.
39 cl, 6 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS OF TREATING CHRONIC INFLAMMATION AND INFLAMMATORY DISEASES | 2014 |
|
RU2680801C2 |
SOLID SOLUTION COMPOSITIONS AND USE IN SEVERE PAIN | 2014 |
|
RU2667977C2 |
COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC INFLAMMATION AND INFLAMMATORY DISEASES | 2012 |
|
RU2635188C2 |
SOLID SOLUTION COMPOSITIONS AND USE IN CHRONIC INFLAMMATION | 2014 |
|
RU2675241C2 |
SOLID SOLUTION COMPOSITIONS AND THEIR USE IN CHRONIC INFLAMMATION | 2014 |
|
RU2779839C2 |
TAPENTADOL COMPOSITIONS FOR PAIN MANAGEMENT | 2008 |
|
RU2497512C2 |
SOLID SOLUTION COMPOSITIONS AND USE IN CARDIOVASCULAR DISEASE | 2014 |
|
RU2674982C2 |
PHARMACEUTICAL COMPOSITIONS OF KETOROLAC | 2017 |
|
RU2677663C1 |
ORAL CELECOXIB COMPOSITION FOR PAIN TREATMENT | 2017 |
|
RU2745196C2 |
PHARMACEUTICAL COMBINATION AND USING IT | 2011 |
|
RU2575775C2 |
Authors
Dates
2019-01-16—Published
2014-01-14—Filed